| Updates on Administration of NOACs in Cardiac & Oncologic Patients |
|
Headline : Physician
Date : Wednesday, 20 September 2023
Start Time : 11:00
End Time : 12:30
Location : International Conference Hall
|
| Endovascular treatments of aortic pathologies- AAA and TAAA, dissection and coarctation |
|
Headline : Physician
Date : Wednesday, 20 September 2023
Start Time : 09:00
End Time : 10:30
Location : Hegmataneh Hall
|
|
Presentations |
|
09:00 - 00:00
|
TBAD management (case based) :
• Acute phase management; medical management and decision making to go for TEVAR or
medical alone
Amin Elahifar Movie : No Access |
|
|
|
09:13 - 00:00
|
• What happens to TBAD patients after 5 years- TEVAR versus Medical alone a literature
review of best treatment options
Ali Moezi Movie : No Access |
|
09:20 - 00:00
|
• Q&A :10 Min
|
|
09:30 - 00:00
|
AAA and TAAA treatment :
• The destiny after EVAR- Long term hazards and their management
Arsis Ahmadieh Movie : No Access |
|
09:38 - 00:00
|
• Endovascular management of hostile neck anatomies including gist of planning
Omid Shafe |
|
09:45 - 00:00
|
• Endoleak issues
• Type 2 endoleaks; are they really important?
Ehsan Shirvani Movie : No Access |
|
|
|
09:55 - 00:00
|
• Q&A:10 Min
|
|
10:05 - 00:00
|
Coarctation of the aorta :
• Which treatment should be done with our best of knowledge? Surgery vs stents
Parham Sadeghipour Movie : No Access |
|
10:12 - 00:00
|
• Endovascular treatment planning in coarctation of the aorta
Jamal Moosavi Movie : No Access |
|
10:20 - 00:00
|
• Q&A :10 Min
|
| VTE challenges@ICCU: Case-based discussion and Debate |
|
Headline : Physician
Date : Thursday, 21 September 2023
Start Time : 16:00
End Time : 17:30
Location : International Conference Hall
|
|
Presentations |
|
|
|
16:15 - 00:00
|
Case 2: How to follow a patient with history of acute PE
Arezoo Mohamadifar Movie : No Access |
|
16:30 - 00:00
|
Case 3: How to treat varicose vein in patient with history of VTE
Omid Shafe Movie : No Access |
|
|
|
17:00 - 00:00
|
Debate: Catheter-based therapies in intermediate-high risk PE /
How to define Intermediate-High risk PE
Reza Ghanavati Movie : No Access |
|
17:08 - 00:00
|
Does imaging improve Intermediate-High risk PE stratification?
Melody Farrashi Movie : No Access |
|
17:16 - 00:00
|
Catheter-based therapies in intermediate-high risk PE :Pros,
Parham Sadeghipour Movie : No Access |
|
17:23 - 00:00
|
Catheter-based therapies in intermediate-high risk PE : Cons,
Farid Rashidi Movie : No Access |
